Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Market Cap	304.97M
Revenue (ttm)	368.66M
Net Income (ttm)	26.69M
Shares Out	141.84M
EPS (ttm)	0.19
PE Ratio	11.43
Forward PE	n/a
Dividend	0.11 (5.12%)
Ex-Dividend Date	Jun 24, 2024

Volume	1,100
Average Volume	27,225
Open	2.140
Previous Close	2.140
Day's Range	2.140 - 2.140
52-Week Range	2.090 - 3.180
Beta	0.19
RSI	42.73
Earnings Date	May 22, 2025

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, manufactures and trades in generic drugs. The company operates through three segments: Manufacturing, Trading, and Investment Holding. It manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. The company also manufactures aquatic, cosmetic, and biotechnology products, as well as traditional herbal medicines, food supplements, over-the-cou...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 1,369
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: YSPSAH

Financial Performance

In 2024, KLSE:YSPSAH's revenue was 368.66 million, an increase of 3.85% compared to the previous year's 355.00 million. Earnings were 26.69 million, a decrease of -28.48%.